Physician profile
Robin E Erwin
NPI 1619217171
$10,575.70
in general payments reported to CMS, 2019-2025
72 companies · $2,344 in 2025
The $2,344 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,134 · 2022: $1,553 · 2023: $2,336 · 2024: $2,208 · 2025: $2,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,806 · Education: $82.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,805.66 |
| Education | $82.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,185.27 | 2021-2025 | |
| Janssen Biotech, INC. | $919.43 | 2021-2025 | Darzalex, Tecvayli, Talvey |
| E.R. Squibb & Sons, L.L.C. | $610.00 | 2021-2025 | Opdivo, Krazati, Opdualag |
| Astrazeneca Pharmaceuticals Lp | $554.66 | 2021-2025 | Imfinzi, Enhertu, Lynparza |
| Pfizer INC. | $492.70 | 2021-2025 | |
| Amgen INC. | $408.21 | 2021-2023 | Blincyto, Kyprolis, Lumakras |
| Celgene Corporation | $340.75 | 2021-2025 | Reblozyl, Opdualag |
| Incyte Corporation | $338.01 | 2021-2025 | Monjuvi, Jakafi, Pemazyre |
| Seagen INC. | $293.27 | 2021-2023 | Adcetris, Padcev, Tukysa |
| Merck Sharp & Dohme LLC | $286.06 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Genentech USA, INC. | $243.21 | 2024-2025 | Tecentriq, Venclexta, Polivy |
| Lilly USA, LLC | $239.37 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Abbvie INC. | $221.59 | 2023-2025 | |
| Daiichi Sankyo INC. | $206.81 | 2021-2025 | Enhertu |
| Deciphera Pharmaceuticals INC. | $187.82 | 2022-2024 | Qinlock |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $176.04 | 2021-2025 | Gilotrif |
| Dendreon Pharmaceuticals LLC | $175.96 | 2021-2025 | Provenge |
| Eisai INC. | $175.90 | 2021-2023 | |
| Jazz Pharmaceuticals INC. | $174.53 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $174.31 | 2021-2025 | Libtayo |
| Pharmacyclics LLC, An Abbvie Company | $173.31 | 2021-2023 | Imbruvica, Epkinly |
| Kite Pharma, INC. | $168.30 | 2021-2025 | Yescarta |
| Takeda Pharmaceuticals U.S.A., INC. | $145.24 | 2024-2025 | Fruzaqla, Ninlaro |
| Janssen Pharmaceuticals, INC | $137.70 | 2023-2024 | Xarelto |
| Stemline Therapeutics INC. | $135.27 | 2023-2025 | Orserdu |
| Glaxosmithkline, LLC. | $134.34 | 2021-2024 | Ojjaara, Zejula, Jemperli |
| Karyopharm Therapeutics INC. | $114.92 | 2021-2023 | Xpovio |
| Array Biopharma INC | $111.40 | 2021-2024 | Lorbrena, Mektovi, Braftovi |
| Pharmacosmos Therapeutics INC. | $102.61 | 2022-2025 | Monoferric |
| Pharmaessentia USA Corporation | $102.05 | 2023-2024 | Besremi |
| Sobi, INC | $101.43 | 2024-2025 | |
| Tersera Therapeutics LLC | $100.67 | 2022-2024 | Zoladex, Quzyttir, Xermelo |
| Genzyme Corporation | $100.21 | 2023-2024 | |
| Gilead Sciences, INC. | $99.16 | 2023 | Trodelvy |
| Coherus Oncology, INC. | $95.34 | 2021-2025 | Loqtorzi |
| Astellas Pharma US INC | $80.73 | 2022-2024 | Xtandi, Padcev |
| Janssen Scientific Affairs, LLC | $79.34 | 2024 | Rybrevant |
| Exelixis INC. | $78.39 | 2021-2025 | Cabometyx |
| Alexion Pharmaceuticals, INC. | $74.80 | 2024-2025 | Ultomiris, Soliris |
| Aveo Pharmaceuticals, INC. | $72.04 | 2022-2025 | Fotivda |
| Mirati Therapeutics, INC. | $64.56 | 2023-2024 | Krazati |
| Octapharma USA, INC. | $61.41 | 2022-2023 | Octagam Immune Globulin (Human) |
| Bayer Healthcare Pharmaceuticals INC. | $56.57 | 2023 | |
| Blueprint Medicines Corporation | $47.46 | 2023 | Ayvakit |
| Progenics Pharmaceuticals, INC. | $44.97 | 2023 | Pylarify |
| Recordati_rare_diseases_inc. | $44.95 | 2021-2023 | Panhematin |
| Adc Therapeutics America, INC. | $42.39 | 2022-2025 | |
| Heron Therapeutics, INC. | $40.99 | 2022 | |
| Myriad Genetic Laboratories, INC. | $40.62 | 2022-2024 | Bracanalysis Cdx |
| Emd Serono, INC. | $39.03 | 2025 | |
| Sumitomo Pharma America, INC. | $37.95 | 2023-2025 | Orgovyx |
| Immunocore Limited | $37.11 | 2025 | Kimmtrak |
| Beone Medicines USA, INC. | $33.64 | 2025 | Brukinsa |
| Servier Pharmaceuticals LLC | $30.70 | 2024-2025 | |
| Csl Behring | $28.19 | 2023 | Hizentra |
| Sun Pharmaceutical Industries INC. | $24.60 | 2023 | Yonsa, Odomzo |
| Rigel Pharmaceuticals, INC. | $24.45 | 2023 | Rezlidhia, Tavalisse |
| Genmab U.S., INC. | $23.90 | 2023 | Epkinly |
| Kyowa Kirin, INC. | $22.84 | 2025 | |
| Pharmaand Gmbh | $22.38 | 2025 | Rubraca |
| Tolmar, INC. | $22.38 | 2025 | Rubraca, Eligard |
| Tolmar Pharmaceuticals, INC. | $21.38 | 2022 | |
| Epizyme, INC. | $19.40 | 2022 | |
| Morphosys, US INC. | $16.79 | 2021 | |
| Global Blood Therapeutics, INC. | $16.75 | 2021 | |
| Alnylam Pharmaceuticals INC. | $15.46 | 2025 | Givlaari |
| Puma Biotechnology, INC. | $15.23 | 2021 | |
| Myovant Sciences INC. | $15.21 | 2022 | |
| Clovis Oncology, INC. | $14.94 | 2021 | |
| Btg International INC. | $14.45 | 2023 | |
| Tactile Systems Technology INC | $12.12 | 2022 | |
| Acceleron Pharma, INC. | $11.73 | 2021 |
Drugs and devices associated with these payments
Darzalex $326Imbruvica $291Enhertu $288Keytruda $286Tecvayli $241Opdivo $227Kisqali $217Pluvicto $213Talvey $195Rybrevant $188Venclexta $160Jaypirca $155Verzenio $155Reblozyl $152Imfinzi $150Scemblix $150Lynparza $141Qinlock $140Xarelto $138Orserdu $135Xtandi $129Libtayo $126Adcetris $123Epkinly $120Welireg $116Lutathera $115Besremi $102Sarclisa $100Tukysa $100Lenvima $99.62Trodelvy $99.16Fruzaqla $97.04Tecentriq $95.39Provenge $93.62Inlyta $86.12Krazati $82.95Elrexfio $82.63Monoferric $78.85Talzenna $78.77Bosulif $69.97Monjuvi $67.92Vonjo $67.57Ojjaara $67.32Ibrance $65.79Polivy $60.68Loqtorzi $57.35Fotivda $56.20Ultomiris $53.50Gilotrif $53.15Zepzelca $52.69Lorbrena $52.36Xpovio $51.97Tasigna $49.35Padcev $48.71Promacta $48.56Ninlaro $48.20Ayvakit $47.46Opdualag $46.92Pylarify $44.97Rubraca $44.76Zoladex $39.91Piqray $38.33Orgovyx $37.95Kimmtrak $37.11Fabhalta $36.62Jakafi $36.37Mektovi $36.00Retevmo $35.90Nubeqa $33.89Doptelet $33.86Brukinsa $33.64Xalkori $32.88Panhematin $31.49Tibsovo $30.70Hizentra $28.19Quzyttir $27.13Bracanalysis Cdx $26.81Odomzo $24.60Yonsa $24.60Tavalisse $24.45Rezlidhia $24.45Udenyca $24.17Carvykti $23.99Octagam Immune Globulin (Human) $23.50Emrelis $23.19Poteligeo $22.84Stivarga $22.68Vitrakvi $22.68Eligard $22.38Jemperli $21.85Zejula $21.85Zynlonta $21.81Soliris $21.30Cabometyx $20.93Erleada $20.14Lunsumio $19.77Columvi $19.77Calquence $19.63Tivdak $19.60Phesgo $19.54
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Erwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.